Chaojiang Gu

1.0k total citations
18 papers, 467 citations indexed

About

Chaojiang Gu is a scholar working on Molecular Biology, Oncology and Virology. According to data from OpenAlex, Chaojiang Gu has authored 18 papers receiving a total of 467 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Oncology and 5 papers in Virology. Recurrent topics in Chaojiang Gu's work include HIV Research and Treatment (5 papers), CAR-T cell therapy research (5 papers) and Virus-based gene therapy research (3 papers). Chaojiang Gu is often cited by papers focused on HIV Research and Treatment (5 papers), CAR-T cell therapy research (5 papers) and Virus-based gene therapy research (3 papers). Chaojiang Gu collaborates with scholars based in China, United States and United Kingdom. Chaojiang Gu's co-authors include Jennifer Kelschenbach, David J. Volsky, Wei Chao, Mary Jane Potash, Tongcun Zhang, Eran Hadas, Alejandra Borjabad, Jia‐Peng Li, Xiang Yuan and Xing‐Hua Liao and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Scientific Reports.

In The Last Decade

Chaojiang Gu

17 papers receiving 465 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chaojiang Gu China 12 165 139 119 86 86 18 467
Fritz Lahrtz Switzerland 8 113 0.7× 125 0.9× 166 1.4× 110 1.3× 59 0.7× 10 632
Stephanie Balcaitis United States 11 127 0.8× 70 0.5× 149 1.3× 77 0.9× 23 0.3× 13 418
Noriko Tonomura United States 9 187 1.1× 121 0.9× 128 1.1× 31 0.4× 52 0.6× 10 752
Irene Canini Italy 14 150 0.9× 135 1.0× 296 2.5× 59 0.7× 29 0.3× 18 910
Michihiro Hashimoto Japan 16 286 1.7× 80 0.6× 34 0.3× 19 0.2× 39 0.5× 31 616
Mitchell D. Krathwohl United States 8 100 0.6× 168 1.2× 275 2.3× 119 1.4× 22 0.3× 8 672
Amelia Escolano United States 15 340 2.1× 158 1.1× 107 0.9× 25 0.3× 42 0.5× 23 959
Sophie Stephenson United Kingdom 15 281 1.7× 65 0.5× 46 0.4× 19 0.2× 44 0.5× 28 625
Albert C. Huang United States 5 198 1.2× 25 0.2× 96 0.8× 39 0.5× 45 0.5× 6 579
Bridget McLaughlin United States 10 165 1.0× 122 0.9× 32 0.3× 12 0.1× 44 0.5× 20 427

Countries citing papers authored by Chaojiang Gu

Since Specialization
Citations

This map shows the geographic impact of Chaojiang Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chaojiang Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chaojiang Gu more than expected).

Fields of papers citing papers by Chaojiang Gu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chaojiang Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chaojiang Gu. The network helps show where Chaojiang Gu may publish in the future.

Co-authorship network of co-authors of Chaojiang Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Chaojiang Gu. A scholar is included among the top collaborators of Chaojiang Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chaojiang Gu. Chaojiang Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Wang, Jun, Hanning Li, Jia‐Peng Li, et al.. (2025). CD24 recruits tumor-associated neutrophils to promote the progression of hepatocellular carcinoma. Journal for ImmunoTherapy of Cancer. 13(8). e012118–e012118.
2.
Hadas, Eran, Jennifer Kelschenbach, Wei Chao, et al.. (2023). CCL2 is required for initiation but not persistence of HIV infection mediated neurocognitive disease in mice. Scientific Reports. 13(1). 6577–6577. 8 indexed citations
3.
Li, Xianlei, Ningqiang Gong, Falin Tian, et al.. (2023). Suppression of cytokine release syndrome during CAR-T-cell therapy via a subcutaneously injected interleukin-6-adsorbing hydrogel. Nature Biomedical Engineering. 7(9). 1129–1141. 47 indexed citations
4.
Zhang, Shangkun, Chaojiang Gu, Lifang Huang, et al.. (2022). The third-generation anti-CD30 CAR T-cells specifically homing to the tumor and mediating powerful antitumor activity. Scientific Reports. 12(1). 10488–10488. 26 indexed citations
5.
Li, Hui, Huimin Zhang, Lijuan Fan, et al.. (2021). STAT3/miR-15a-5p/CX3CL1 Loop Regulates Proliferation and Migration of Vascular Endothelial Cells in Atherosclerosis. International Journal of Medical Sciences. 18(4). 964–974. 16 indexed citations
6.
He, Xiaohong, et al.. (2021). Rapid Diagnosis of HIV-1 virus by Near Infrared Spectroscopy: based on Partial least squares regression. SHILAP Revista de lepidopterología. 271. 3067–3067. 1 indexed citations
7.
Wei, Jia, Min Xiao, Zekai Mao, et al.. (2020). Anti CD19/22 Cocktail CAR T-Cell Therapy Can Improve the Outcomes of Patients with TP53-Mutated Relapsed/Refractory B-Cell Lymphoma. Blood. 136(Supplement 1). 43–43. 1 indexed citations
8.
Cao, Wenyue, Jia Wei, Na Wang, et al.. (2020). Entecavir prophylaxis for hepatitis B virus reactivation in patients with CAR T-cell therapy. Blood. 136(4). 516–519. 32 indexed citations
9.
10.
Gu, Chaojiang, Alejandra Borjabad, Eran Hadas, et al.. (2018). EcoHIV infection of mice establishes latent viral reservoirs in T cells and active viral reservoirs in macrophages that are sufficient for induction of neurocognitive impairment. PLoS Pathogens. 14(6). e1007061–e1007061. 62 indexed citations
11.
Xu, Jinhuan, Qiuxiang Wang, Hao Xu, et al.. (2018). Anti-BCMA CAR-T cells for treatment of plasma cell dyscrasia: case report on POEMS syndrome and multiple myeloma. Journal of Hematology & Oncology. 11(1). 128–128. 40 indexed citations
12.
Yuan, Xiang, Xing‐Hua Liao, Chengxi Yu, et al.. (2017). MiR-93-5p inhibits the EMT of breast cancer cells via targeting MKL-1 and STAT3. Experimental Cell Research. 357(1). 135–144. 72 indexed citations
13.
Yuan, Xiang, Xing‐Hua Liao, Huan Qin, et al.. (2017). MRTF-A-miR-206-WDR1 form feedback loop to regulate breast cancer cell migration. Experimental Cell Research. 359(2). 394–404. 29 indexed citations
14.
Yuan, Xiang, Xing‐Hua Liao, Hui Li, et al.. (2017). Myocardin and Stat3 act synergistically to inhibit cardiomyocyte apoptosis. Oncotarget. 8(59). 99612–99623. 3 indexed citations
15.
He, Hongxia, Leroy R. Sharer, Wei Chao, et al.. (2013). Enhanced Human Immunodeficiency Virus Type 1 Expression and Neuropathogenesis in Knockout Mice Lacking Type I Interferon Responses. Journal of Neuropathology & Experimental Neurology. 73(1). 59–71. 37 indexed citations
16.
Kelschenbach, Jennifer, Eran Hadas, Chaojiang Gu, et al.. (2011). Mice Chronically Infected with Chimeric HIV Resist Peripheral and Brain Superinfection: A Model of Protective Immunity to HIV. Journal of Neuroimmune Pharmacology. 7(2). 380–387. 31 indexed citations
17.
Gu, Chaojiang, et al.. (2009). Structure-function analysis of mutant RNA-dependent RNA polymerase complexes with VPg. Biochemistry (Moscow). 74(10). 1132–1141. 4 indexed citations
18.
Gu, Chaojiang, Congyi Zheng, Lili Shi, et al.. (2006). Plus- and minus-stranded foot-and-mouth disease virus RNA quantified simultaneously using a novel real-time RT-PCR. Virus Genes. 34(3). 289–298. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026